These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8526788)

  • 1. Development of immunosorbents for apoB-containing lipoproteins apheresis.
    Pokrovsky SN; Sussekov AV; Adamova IY; Afanasieva OI; Benevolenskaya GF; Konovalov GA; Kukharchuk VV
    Artif Organs; 1995 Jun; 19(6):500-5. PubMed ID: 8526788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein (a) and Low-density lipoprotein apolipoprotein B metabolism following apheresis in patients with elevated lipoprotein(a) and coronary artery disease.
    Ma L; Waldmann E; Ooi EMM; Chan DC; Barrett HPR; Watts GF; Parhofer KG
    Eur J Clin Invest; 2019 Feb; 49(2):e13053. PubMed ID: 30447089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lipid- and lipoprotein- [LDL-Lp(a)] apheresis techniques. Updating.
    Stefanutti C; Morozzi C; Perrone G; Di Giacomo S; Vivenzio A; D'Alessandri G
    G Chir; 2012; 33(11-12):444-9. PubMed ID: 23140934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LDL-apheresis in two patients with extremely elevated lipoprotein (a) levels.
    Bambauer R; Schiel R; Keller HE; Latza R
    Int J Artif Organs; 1995 May; 18(5):286-90. PubMed ID: 8567105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein (LDL) oxidizability before and after LDL apheresis.
    Donner MG; Parhofer KG; Richter WO; Schwandt P
    Metabolism; 1999 Jul; 48(7):881-6. PubMed ID: 10421230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical data.
    Pokrovsky SN; Sussekov AV; Afanasieva OI; Adamova IY; Lyakishev AA; Kukharchuk VV
    Chem Phys Lipids; 1994 Jan; 67-68():323-30. PubMed ID: 8187230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct adsorption of low-density lipoprotein and lipoprotein(a) from whole blood: results of the first clinical long-term multicenter study using DALI apheresis.
    Bosch T; Lennertz A; Schenzle D; Dräger J;
    J Clin Apher; 2002; 17(4):161-9. PubMed ID: 12494408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum lipoprotein (a) levels during treatment with LDL apheresis for homozygous familial hypercholesterolemia].
    Lasunción MA; Teruel JL; Alvarez JJ; Gómez-Coronado D; Ortuño J; Herrera E
    Med Clin (Barc); 1992 Oct; 99(14):541-4. PubMed ID: 1434990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific Lp(a) apheresis: A tool to prove lipoprotein(a) atherogenicity.
    Pokrovsky SN; Afanasieva OI; Safarova MS; Balakhonova TV; Matchin YG; Adamova IYU; Konovalov GA; Ezhov MV
    Atheroscler Suppl; 2017 Nov; 30():166-173. PubMed ID: 29096833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) apheresis.
    Pokrovsky SN; Afanasieva OI; Ezhov MV
    Curr Opin Lipidol; 2016 Aug; 27(4):351-8. PubMed ID: 27213629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels.
    Kroon AA; van't Hof MA; Demacker PN; Stalenhoef AF
    Atherosclerosis; 2000 Oct; 152(2):519-26. PubMed ID: 10998482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the long-term efficacy and selectivity of immunoadsorption columns for low density lipoprotein apheresis.
    Jovin IS; Taborski U; Müller-Berghaus G
    ASAIO J; 2000; 46(3):298-300. PubMed ID: 10826740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HELP-LDL-apheresis on outcomes in patients with advanced coronary atherosclerosis and severe hypercholesterolemia.
    Park JW; Merz M; Braun P
    Atherosclerosis; 1998 Aug; 139(2):401-9. PubMed ID: 9712348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosorbent for selective removal of lipoprotein (a) from human plasma: in vitro study.
    Pokrovsky SN; Adamova IYu ; Afanasieva OY; Benevolenskaya GF
    Artif Organs; 1991 Apr; 15(2):136-40. PubMed ID: 1827976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immune response following extracorporeal immunoadsorption therapy of patients with hypercholesterolemia.
    Gordon BR; Sloan BJ; Parker TS; Saal SD; Levine DM; Rubin AL
    Transfusion; 1990 May; 30(4):327-32. PubMed ID: 2190366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein-apheresis in two patients with extremely elevated lipoprotein (a) levels.
    Bambauer R; Schiel R; Klinkmann J; Latza R
    J Clin Apher; 1996; 11(2):78-80. PubMed ID: 8844436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific Lipoprotein(a) apheresis attenuates progression of carotid intima-media thickness in coronary heart disease patients with high lipoprotein(a) levels.
    Ezhov MV; Safarova MS; Afanasieva OI; Pogorelova OA; Tripoten MI; Adamova IY; Konovalov GA; Balakhonova TV; Pokrovsky SN
    Atheroscler Suppl; 2015 May; 18():163-9. PubMed ID: 25936321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short- and long-term effects of LDL-apheresis on lipoprotein (a) serum levels.
    Ritter MM; Sühler K; Richter W; Schwandt P
    Clin Chim Acta; 1990 Dec; 195(1-2):9-15. PubMed ID: 2151209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct adsorption of low-density lipoprotein by DALI-LDL-apheresis: results of a prospective long-term multicenter follow-up covering 12,291 sessions.
    Bosch T; Gahr S; Belschner U; Schaefer C; Lennertz A; Rammo J;
    Ther Apher Dial; 2006 Jun; 10(3):210-8. PubMed ID: 16817783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apheresis for severe hypercholesterolaemia and elevated lipoprotein(a).
    Waldmann E; Parhofer KG
    Pathology; 2019 Feb; 51(2):227-232. PubMed ID: 30611543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.